Table 6.
Coding | Description |
---|---|
ICD-10 coding | |
Z11.59 | Asymptomatic, no known exposure, results unknown or negative |
Z03.8181 | Possible exposure to COVID-19, ruled out |
Z20.828 | Contact with COVID-19, suspected exposure |
CPT/HCPCS code | |
U0001 | CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel |
U0002a | 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC |
U0003 | Infectious agent DNA or RNA; SARS-CoV-2 amplified probe technique, making use of high throughput technologies as described by CMS-2020-01-R |
87635a | Infectious agent DNA or RNA; SARS-CoV-2, amplified probe technique |
Abbreviations used: CPT, current procedural terminology; HCPCS, Healthcare Common Procedure Coding System; nCoV, novel coronavirus; CMS, Centers for Medicare & Medicaid Services; CDC, Centers for Disease Control and Prevention; RT-PCR, reverse transcription polymerase chain reaction; COVID-19, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Note: Patient assessment and specimen collection can be billed by a physician or nonphysician provider using CPT code 99211, with funds being distributed under a financial relationship to the pharmacist who meets incident-to-physician-services billing requirements.
Codes that a pharmacy would use to directly bill Medicare as a clinical laboratory.